Jefferies London Healthcare Conference Julie Brown, CFO
|
|
- Marjorie Wheeler
- 6 years ago
- Views:
Transcription
1 Jefferies London Healthcare Conference Julie Brown, CFO
2 Forward looking statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations. 2
3 Agenda 1. Our business and strategic priorities 2. Progress to date 3. Insight into recent announcements ArthoCare Group optimisation Syncera Mid-Tier Strategy in Emerging Markets 4. Summary 3
4 Our business ALLEVYN Wound Dressings Collagenase SANTYL Ointment Enzymatic debrider Advanced Wound Management VISIONAIRE Patient Matched Instrumentation PICO Negative Pressure Wound Therapy Knee Implants DYONICS PLATINUM Shaver Blades Other Arthroscopic Enabling Technologies Sports Medicine (Joint Repair) $4.35bn revenues (2013) Trauma Hip Implants VERILAST 30-year wear claim ANTHOLOGY Primary Hip System FAST FIX 360 Meniscal Repair System HEALICOIL PK PERI-LOC TRIGEN INTERTAN 4 Suture Anchor Periarticular Locked Plating System Intertrochanteric Antegrade Nail
5 Our position leading share and a diversified business S&N 11% Biomet 12% Other 15% Hip & Knee Implants Stryker 19% Zimmer 23% Segment Size: $14.0bn Growth: 3% DePuy 20% Conmed 5% Stryker 10% Other 17% DePuy Mitek 15% Sports Medicine Arthrex 28% S&N 25% Other, 9% Zimmer 6% Biomet 6% S&N 10% Trauma & Extremities Stryker 22% Segment Size: $4.9bn Growth: 7% DePuy Synthes 47% KCI 22% Other 38% Advanced Wound Management Convatec 8% Molnlycke 12% S&N 20% Segment Size: $4.3bn Growth: 6% Segment Size: $6.7bn Growth: 4% Data: 2013 Estimates generated by Smith & Nephew based upon public sources and internal analysis *Acquisition of Systagenix by KCI completed Oct 2013 *Sports Medicine consists of Repair, Access & Resection 5
6 What drives underlying market growth? Demographics Emerging markets Technology Prevalence Lifestyle Diabetes Economics 6
7 Strategic Priorities Winning in Established Markets Accelerating development in Emerging Markets Innovating for value Simplifying and improving our operating model Supplement organic growth through acquisitions 7
8 Capital allocation framework Reinvest for organic growth Progressive dividend policy Acquisitions in line with strategy Return excess to shareholders Maintain strong balance sheet to ensure solid investment grade credit metrics 8
9 Agenda 1. Our business and strategic priorities 2. Progress to date 3. Insight into recent announcements ArthoCare Group optimisation Syncera Mid-Tier Strategy in Emerging Markets 4. Summary 9
10 Shareholder Value Progressing our Strategic Priorities Established Markets Focused investment & management. Greater efficiency. Emerging Markets China. Distributor acquisitions. Mid-tier. Innovation Increased R&D. Launch momentum. Strong pipeline. Simplification More agile and efficient. Group optimisation plan. Acquisitions 13 deals, $2.8bn consideration (at H1) 10
11 Rebalancing Smith & Nephew Lower Higher Growth Growth 65% 35% Lower Growth 65% Proportion of Revenue * Excluding Clinical Therapies ** H including proforma ArthroCare for full period Higher Growth 50% Lower Growth 50% 2011* 2014 H1** Franchises / Geographies Higher Growth Sports Medicine Joint Repair ArthroCare Trauma & Extremities Gynecology Advanced Wound Bioactives Advanced Wound Devices Emerging markets (all franchises) Lower Growth Enabling Technologies (Established mkts) Reconstruction (Established mkts) Advanced Wound Care (Established mkts) 11
12 Agenda 1. Our business and strategic priorities 2. Progress to date 3. Insight into recent announcements ArthoCare Group Optimisation Syncera Mid-Tier Strategy in Emerging Markets 4. Summary 12
13 ArthroCare - compelling strategic rationale Creates a comprehensive product portfolio Arthroscopic Enabling Technologies (COBLATION ) Joint Repair (Shoulder) Opportunities to drive greater revenue sales force enhancement geographic penetration outside US options in ENT Strong pipeline and R&D COBLATION & Joint Repair expertise new product development resources Great fit for Smith & Nephew 13
14 Group optimisation plan four levers Optimising Functions Driving Procurement Savings Develop best in class global support functions Drive savings and capability investments Increasing overall efficiency/ agility Simplifying Operating Model Simplify our management structure Liberating resources to re-invest in critical areas to drive growth Optimising Locations Rationalise property portfolio 14
15 The Syncera solution Value 1 Hip/Knee implant solutions for progressive customers Clinically proven 2 Products from Smith & Nephew addressing the vast majority of primary joint procedures Automation 3 Customer interfaces using innovative technology to reduce cost while improving efficiency Full support 4 High levels of service and support Attractive economics 5 Transparent prices driving substantial benefit for providers 15
16 Mid-tier new emerging markets business model Mid-tier commercial model Independent Mid-tier sales organisation Good quality products at lower prices Dedicated leadership Manufacturing & design efficiency Common shared services Different business model Different service model Different brand Separate sales channels Streamlined sales & marketing Collaboration with premium-tier organisation 16
17 Agenda 1. Our business and strategic priorities 2. Progress to date 3. Insight into recent announcements ArthoCare Group optimisation Syncera Mid-Tier Strategy in Emerging Markets 4. Summary 17
18 Summary Delivering on our Strategic Priorities re-balancing the growth profile enhancing the returns through cost and tax optimisation generating cash flow for value creating acquisitions or shareholder returns 18
19 Questions
20 20
33rd Annual J.P. Morgan Healthcare Conference Olivier Bohuon, CEO
33rd Annual J.P. Morgan Healthcare Conference Olivier Bohuon, CEO Forward looking statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements
More informationExane BNP Paribas Conference 10 May 2010
Exane BNP Paribas Conference 10 May 2010 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act
More informationJP Morgan Healthcare Conference. 11 January 2010
JP Morgan Healthcare Conference 11 January 2010 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform
More informationCEO s Round Table June
CEO s Round Table June 2009 0 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In
More informationThe Interim Results of smith&nephew for 2003: reduced pain, faster recovery, more cost-effective treatments. Sales growth was 11% and we helped
* The Interim Results of smith&nephew for 2003: reduced pain, faster recovery, more cost-effective treatments. Sales growth was 11% and we helped thousands of people get back to active lives. Chief Executive
More informationSupporting healthcare professionals for over 150 years
Supporting healthcare professionals for over 150 years ANNUAL REPORT 2013 Contents 2 42 86 Innovation Trust Performance * Financial highlights 4 Chairman s statement 5 Smith & Nephew today 6 Chief Executive
More informationSucceeding in challenging times In 2016 Smith & Nephew faced and overcame challenges.
2 OVERVIEW OUR BUSINESS & MARKETPLACE OPERATIONAL FINANCIAL RISK GOVERNANCE ACCOUNTS CHAIRMAN S STATEMENT Succeeding in challenging times In Smith & Nephew faced and overcame challenges. DEAR SHAREHOLDER,
More informationJ.P. Morgan Healthcare Conference January 10, 2018
J.P. Morgan Healthcare Conference January 10, 2018 Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the
More informationPROVIDING LEADERSHIP 2 OVERVIEW SMITH & NEPHEW ANNUAL REPORT 2017 CHAIRMAN S STATEMENT
2 OVERVIEW SMITH & NEPHEW ANNUAL REPORT 2017 CHAIRMAN S STATEMENT PROVIDING LEADERSHIP The Board approaches 2018 with optimism. Olivier has built a strong foundation and we expect to attract someone of
More informationJefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q
Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements
More informationCase No COMP/M SMITH & NEPHEW / CENTERPULSE. REGULATION (EEC) No 4064/89 MERGER PROCEDURE. Article 6(1)(b) NON-OPPOSITION Date: 27/05/2003
EN Case No COMP/M.3146 - SMITH & NEPHEW / CENTERPULSE Only the English text is available and authentic. REGULATION (EEC) No 4064/89 MERGER PROCEDURE Article 6(1)(b) NON-OPPOSITION Date: 27/05/2003 Also
More informationMORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016
MORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments
More informationSafe Harbor Statement
Safe Harbor Statement This presentation may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of
More informationNuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016
NuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016 Safe Harbor Statements Forward-looking information and non-gaap measures NuVasive, Inc. ( NuVasive, NUVA or the Company ) cautions
More informationThe Growth Opportunity Jim Lawrence Chief Financial Officer. Unilever Investor Seminar Englewood Cliffs, NJ November 23-24, 2009
The Growth Opportunity Jim Lawrence Chief Financial Officer Unilever Investor Seminar Englewood Cliffs, NJ November 23-24, 2009 Welcome to Englewood Cliffs!!! Sao Paulo December 2005 Warsaw August 2006
More informationBiopharmaceuticals Investor & Analyst Day
Adequate picture Biopharmaceuticals Investor & Analyst Day Strategic perspective on Merck KGaA, Darmstadt, Germany Karl-Ludwig Kley CEO Darmstadt, Germany September 18, 2014 Disclaimer Remarks All comparative
More informationMylan. Raymond James 40 th Annual Institutional Investors Conference March 05, 2019
Mylan Raymond James 40 th Annual Institutional Investors Conference March 05, 2019 Forward-Looking Statements This presentation contains forward-looking statements. These statements are made pursuant to
More informationInvestor Presentation. November 26, 2013
Investor Presentation November 26, 2013 Forward-Looking Statements This presentation may contain forward-looking statements as defined under U.S. federal securities laws. These statements reflect management's
More informationUnlocking Our Growth Opportunity
Unlocking Our Growth Opportunity Thomas Seifert EVP and Chief Financial Officer Forward Looking Statements This presentation contains statements regarding our projected financial and business results,
More informationEXANE Conference. Jérôme Contamine, Executive Vice President, Chief Financial Officer. Paris June 13, 2017
EXANE Conference Jérôme Contamine, Executive Vice President, Chief Financial Officer Paris June 13, 2017 Forward Looking Statements This presentation contains forward-looking statements as defined in the
More informationMorgan Stanley Conference. November 15, 2017
Morgan Stanley Conference November 15, 2017 1 Forward Looking Statements Certain statements in this release or presentation, other than purely historical information, including estimates, projections,
More informationTeva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019
Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference Kåre Schultz President and CEO January 7, 2019 Cautionary Note Regarding Forward-Looking Statements 2 This presentation contains forward-looking
More informationInvestor Presentation
Siemens Ltd., 2 www.siemens.co.in Disclaimer This presentation has been prepared solely for use at the investor/analyst presentation. By attending the meeting where this presentation is made, or by reading
More informationFORWARD LOOKING STATEMENTS
1 FORWARD LOOKING STATEMENTS Certain statements included in this presentation are "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements are made based
More informationBank of America Merrill Lynch Healthcare Conference. September 13, 2013
Bank of America Merrill Lynch Healthcare Conference September 13, 2013 Safe Harbor Statement This presentation contains forward-looking statements that are based on management s current expectations and
More informationCEO Presentation Annual General Meeting
ASX code: LBT lbtinnovations.com CEO Presentation Annual General Meeting Adelaide, Australia 21 October 2015 Lusia Guthrie, CEO Disclaimer This document contains certain forward-looking statements that
More informationAccelerating our strategy: GSK to acquire full ownership of Consumer Healthcare Business
Accelerating our strategy: GSK to acquire full ownership of Consumer Healthcare Business Buyout of Novartis stake Strategic review of Horlicks and other Consumer Healthcare Nutrition products Cautionary
More informationInvestor Presentation. January 12, 2017
Investor Presentation January 12, 2017 SAFE HARBOR STATEMENT This presentation contains certain forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking
More informationDisclaimer Forward-Looking Statements Industry and Market Data Non-GAAP Financial Information
Disclaimer Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Securities Act of 1933, as amended (the Securities Act ), the Securities Exchange Act
More informationAnika Therapeutics, Inc.
Anika Therapeutics, Inc. Jefferies Global Healthcare Conference June 4, 2015 Safe Harbor Statement The statements made in this presentation that are not statements of historical fact are forward looking
More informationTesco Investor and Analyst Seminar
Tesco Investor and Analyst Seminar Health and Safety Fire exit Fire exit Fire exit Fire exit Fire exit 2 Maximising the mix to achieve a 3.5% 4.0% Group margin Trevor Masters, Matt Davies, Duncan Hoy,
More informationSafe harbour statement
Vindi Banga President Foods Deutsche Bank Conference 11th June 2007 Safe harbour statement This presentation may contain forward-looking statements, including 'forward-looking statements' within the meaning
More informationThe Future of Consumer Health Care
The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More
More informationFocusing Our Portfolio & Utilizing Our Financial Strength
Focusing Our Portfolio & Utilizing Our Financial Strength Bank of America Merrill Lynch 2017 Asia Pacific Telecom, Media & Technology Conference Ann Nicholson Division Vice President, Investor Relations
More informationADVANCED ORTHOPEDIC TECHNOLOGIES, IMPLANTS AND REGENERATIVE PRODUCTS
ADVANCED ORTHOPEDIC TECHNOLOGIES, IMPLANTS AND REGENERATIVE PRODUCTS HLC052C August 2014 Melissa Elder Project Analyst ISBN: 1-56965-893-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
More informationDeutsche Bank Healthcare Conference
Deutsche Bank Healthcare Conference Jérôme Contamine, Executive Vice President, Chief Financial Officer Boston May 4, 2017 Forward Looking Statements This presentation contains forward-looking statements
More informationWeight Watchers International, Inc.
Weight Watchers International, Inc. Nicholas Hotchkin Chief Financial Officer November 2014 1 Forward-Looking Statements The following information contains forward-looking statements within the meaning
More informationMike Roman. Chief Operating Officer & Executive Vice President. Bank of America Merrill Lynch Global Industrials Conference.
Mike Roman Chief Operating Officer & Executive Vice President Bank of America Merrill Lynch Global Industrials Conference March 22, 2018 1 Building strength-on-strength and positioned for growth 2017 Executing
More informationA New Day in Orthopedic Devices. Proven Products + Highest Quality Manufacturing + Lowest Cost = WE WIN!
A New Day in Orthopedic Devices Proven Products + Highest Quality Manufacturing + Lowest Cost = WE WIN! August 26, 2016 THE PROBLEM: UNSUSTAINABLE ORTHOPEDIC SURGERY AND DEVICE COSTS Aging, active population:
More informationFINANCIAL PERSPECTIVES
FINANCIAL PERSPECTIVES M³ - Meet Merck Management Marcus Kuhnert, CFO Darmstadt December 10, 2015 Disclaimer Cautionary Note Regarding Forward-Looking Statements This communication may include forward-looking
More informationRecommended acquisition of The BSS Group plc. 5 July 2010
Recommended acquisition of The BSS Group plc 5 July 2010 Important information This document is being made available only to persons who fall within the exemptions contained in Article 19 and Article 49
More informationCautions Concerning Forward-looking Statements
1 Cautions Concerning Forward-looking Statements These presentations contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things,
More informationWESTFALIA AUTOMOTIVE ACQUISITION AUGUST 25, 2016
WESTFALIA AUTOMOTIVE ACQUISITION AUGUST 25, 2016 1 SAFE HARBOR STATEMENT FORWARD-LOOKING STATEMENTS This presentation may contain "forward-looking statements" as defined in the Private Securities Litigation
More informationUnilever - CAGNY. Graeme Pitkethly / Richard Williams 22 nd February 2018
Unilever - CAGNY Graeme Pitkethly / Richard Williams 22 nd February 2018 Richard Williams SAFE HARBOUR STATEMENT This announcement contains forward-looking statements, including 'forward-looking statements'
More informationAcquisition of KLX Inc.
Acquisition of KLX Inc. May 1, 2018 Forward-Looking Information Forward-Looking Information Is Subject to Risk and Uncertainty Certain statements in this document may be forward-looking within the meaning
More informationUnited States Orthopedic Bone Cement and Casting Materials Market. Outlook to 2020
United States Orthopedic Bone Cement and Casting Materials Market Reference Code: GDMECC0008DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2
More informationInvestor Presentation May 2018
Investor Presentation May 2018 FORWARD-LOOKING STATEMENTS Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking statements within the meaning
More informationAnika Therapeutics, Inc.
Anika Therapeutics, Inc. Canaccord Genuity 34th Annual Growth Conference August 14 th, 2014 Safe Harbor Statement The statements made in this presentation, which are not statements of historical fact,
More informationProposal to Acquire Andrew Corporation
Proposal to Acquire Andrew Corporation Creating The Global Leader in Providing Last Mile Solutions for Communications Networks Frank Drendel Chairman and Chief Executive Officer Brian Garrett President
More informationLEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS
LEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS SAFE HARBOR STATEMENT This presentation contains forward-looking statements that are based
More informationDeutsche Bank Health Care Conference
Deutsche Bank Health Care Conference May 8, 2018 NASDAQ: ANIK0 Safe Harbor Statement The statements made in, and during the course of, this presentation that are not statements of historical fact, including
More informationInvestor presentation March 21, 2016
Investor presentation March 21, 2016 Forward-Looking Statements 2 Note on forward-looking statements: This document contains forward-looking statements within the meaning of U.S. federal securities laws,
More informationCSC Separating Into Two Industry Leading Public Companies. May 19, 2015
CSC Separating Into Two Industry Leading Public Companies May 19, 2015 Forward looking statements All written or oral statements made by CSC at this meeting or in these presentation materials that do not
More informationING Benelux Conference. How soft factors can reap hard profits. Paul Polman - CEO. Safe harbour statement. 7 th April 2011
ING Benelux Conference Industrial Revolution - How soft factors can reap hard profits Paul Polman - CEO 7 th April 2011 Safe harbour statement This announcement may contain forward-looking statements,
More informationA Leading Global Health Care Group
A Leading Global Health Care Group Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors General Presentation, Fresenius SE & Co. KGaA, Investor Relations Copyright, August 2016
More informationNew Cardinal Health (Post-Spin)
New Cardinal Health (Post-Spin) George Barrett Vice Chairman and Chief Executive Officer Healthcare Supply Chain Services and Chief Executive Officer Cardinal Health, Inc. (post-spin) January 14, 2009
More informationA LEADING GLOBAL HEALTH CARE GROUP. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY
A LEADING GLOBAL HEALTH CARE GROUP Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements
More informationTaylor Acquisition Overview. May 18, 2018
Taylor Acquisition Overview May 18, 2018 Forward Looking Statements Statements made in this presentation or otherwise attributable to the company regarding the company s business which are not historical
More informationBaird 2018 Global Industrial Conference. Jim Lico President & CEO
Baird 2018 Global Industrial Conference Jim Lico President & CEO FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Statements in this presentation that are not strictly historical, statements regarding
More informationAgilent Technologies First Quarter Fiscal 2017 Conference Call Prepared Remarks
Agilent Technologies First Quarter Fiscal 2017 Conference Call Prepared Remarks ALICIA RODRIGUEZ Thank you, and welcome everyone to Agilent's First Quarter Conference Call for Fiscal Year 2017. With me
More informationR1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business
R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business Investor Presentation February 26, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation
More informationVAPR VUE RADIOFREQUENCY SYSTEM, WITH COOLPULSE TECHNOLOGY
VAPR VUE RADIOFREQUENCY SYSTEM, WITH COOLPULSE TECHNOLOGY Differentiation That Matters: So You Can Ablate Efficiently, Yet Safely The next generation in arthroscopic radiofrequency ablation SHOULDER /
More informationIBM Business Perspective 2012
IBM Business Perspective 2012 Patricia Murphy Vice President, Investor Relations 2009 IBM Corporation Certain comments made in this presentation may be characterized as forward looking under the Private
More informationRTIX Investor Presentation
RTIX Investor Presentation Camille Farhat President and CEO Jonathon Singer CF&AO September 2018 Forward Looking Statements This communication contains forward-looking statements within the meaning of
More informationWilliam Blair Growth Stock Conference. Jim Lico President & CEO
William Blair Growth Stock Conference Jim Lico President & CEO FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Statements in this presentation that are not strictly historical, statements regarding
More informationFinancial Discussion. James Kavanaugh Senior Vice President and Chief Financial Officer IBM
Financial Discussion James Kavanaugh Senior Vice President and Chief Financial Officer IBM 1 IBM 2018 Investor Briefing Our differentiated value proposition is driven by innovative technology, industry
More informationPfizer Completes Acquisition of Hospira
For immediate release: September 3, 2015 Media Contact: Joan Campion (212) 733-2798 Investor Contact: Chuck Triano (212) 733-3901 Pfizer Completes Acquisition of Hospira Creates a leading Global Established
More informationOverview and Progress Update: Medicare Performance Initiative (MPI)
Overview and Progress Update: Medicare Performance Initiative (MPI) Britt Reynolds, President Hospital Operations Scott Richardson, Senior Vice President Operations Finance and Performance Management &
More informationpsivida Transforms into Commercial Stage Specialty BioPharmaceutical Company ASCRS April 12, 2018 NASDAQ: EYPT
psivida Transforms into Commercial Stage Specialty BioPharmaceutical Company OIS @ ASCRS April 12, 2018 NASDAQ: EYPT Forward Looking SAFE HARBOR STATEMENTS UNDER THE PRIVATE SECURITIES LITIGATION REFORM
More informationSafe Harbor Statement & Non-GAAP Information
1 Safe Harbor Statement & Non-GAAP Information This presentation should be viewed in conjunction with PepsiCo s webcast presentation at the Consumer Analyst Group of New York Conference on February 20,
More informationTriNet Group, Inc. William Blair Growth Company Conference June 2017
TriNet Group, Inc. William Blair Growth Company Conference June 2017 Disclaimer Cautionary Note Regarding Forward-Looking Statements and Other Financial Information This presentation contains statements
More informationJEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER
JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER SAFE HARBOR STATEMENT Certain statements made during the course of this presentation may
More informationGrowth as a process. Dan Henson Bank of America Conference September 18, 2006
as a process Dan Henson Bank of America Conference September 8, 006 This document contains "forward-looking statements" - that is, statements related to future, not past, events. In this context, forward-looking
More informationMorgan Stanley Global Consumer Conference
Morgan Stanley Global Consumer Conference Ralph Edmondson, Head of Investor Relations New York - November 2011 Important information This presentation has been prepared by British American Tobacco p.l.c.
More informationJefferies 2015 Global Healthcare Conference June 3, 2015
Jefferies 2015 Global Healthcare Conference June 3, 2015 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act
More informationDANAHER BUSINESS SYSTEM Tom Joyce, President & CEO Dan Comas, EVP & CFO MAY 2018
DANAHER BUSINESS SYSTEM Tom Joyce, President & CEO Dan Comas, EVP & CFO MAY 2018 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding
More informationImplementation of Portfolio Strategy in Today s Global Economy
Implementation of Portfolio Strategy in Today s Global Economy Kurtis Klein, RPh Vice President Corporate Strategy & Business Development ALCON LABORATORIES, INC. Agenda Corporate overview Alcon Laboratories
More informationHealth Care Worldwide. Crédit Suisse Global Credit Products Conference October 1, Barcelona
Health Care Worldwide Crédit Suisse Global Credit Products Conference October 1, 2015 - Barcelona Safe Harbor Statement This presentation contains forward-looking statements that are subject to various
More informationTriNet Group, Inc. Investor Presentation November 2017
TriNet Group, Inc. Investor Presentation November 2017 Disclaimer Cautionary Note Regarding Forward-Looking Statements and Other Financial Information This presentation contains statements that are not
More informationPerformance for the Second Quarter ended September 30, 2010
Performance for the Second Quarter ended September 30, 2010 S. Gopalakrishnan Chief Executive Officer and Managing Director S. D. Shibulal Chief Operating Officer and Director Safe Harbour Certain statements
More informationMarket Analysis & Segmentation. Gary Phillips CEO Bioshares 29 July 2016
Market Analysis & Segmentation Gary Phillips CEO Bioshares 29 July 2016 1 Forward looking statement This document contains forward looking statements, including statements concerning Pharmaxis future financial
More informationFiscal 2018 Fourth Quarter Earnings Call April 10, 2019
Fiscal 2018 Fourth Quarter Earnings Call April 10, 2019 Forward Looking Statements This presentation may contain forward-looking statements, including, but not limited to, anticipated net earnings per
More informationFortive s Binding Offer to Acquire Johnson & Johnson s Advanced Sterilization Products Business June 6, 2018
Fortive s Binding Offer to Acquire Johnson & Johnson s Advanced Sterilization Products Business June 6, 2018 FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Forward Looking Statements: Statements
More informationInge Thulin. Chairman of the Board, President and CEO. Bernstein Strategic Decisions Conference. June 1, 2017
Inge Thulin Chairman of the Board, President and CEO Bernstein Strategic Decisions Conference June 1, 2017 1 Forward looking statement This presentation contains forward-looking information about 3M's
More informationGeneral Employment Announces Results for Fiscal 2015 Fourth Quarter and Year End
December 30, 2015 General Employment Announces Results for Fiscal 2015 Fourth Quarter and Year End Company Provides Combined Select Pro Forma Financial Information NAPERVILLE, IL -- (Marketwired) -- 12/30/15
More informationCapital Market Day June 12, 2012
Capital Market Day 2012 June 12, 2012 Product Segments IV Drugs John Ducker Member of the Management Board President Region North America Capital Market Day Fresenius Kabi, June 12, 2012 Agenda 1 2 3 4
More informationFor personal use only
GALE Pacific Investor Presentation Results to 30 June 2015 September 2015 Who we are GALE Pacific manufactures and markets branded screening, shading and home improvement products. We are a world leader
More informationCB&I Investor Presentation March 2017
A World of Solutions CB&I Investor Presentation March 2017 A Leading Provider of Technology and Infrastructure for the Energy Industry Safe Harbor Statement This presentation contains forward-looking statements
More informationICON plc. JP Morgan 33 rd Annual Healthcare Conference. Mr Ciaran Murray, Chief Executive Officer, ICON Plc 13 TH Jan 2015
ICON plc JP Morgan 33 rd Annual Healthcare Conference Mr Ciaran Murray, Chief Executive Officer, ICON Plc 13 TH Jan 2015 Forward Looking Statements Certain statements in today s presentation will be forward
More informationFor personal use only
Company Update 22 May 2017 We Generate Change 1 Disclaimer The material in this presentation has been prepared by ReNu Energy Limited (ABN 55 095 006 090) and is general background information about ReNu
More informationSmith & Nephew is a leading portfolio medical technology company
2 Strategic report Smith & Nephew Annual Report 2018 At a glance Smith & Nephew is a leading portfolio medical technology company OUR PURPOSE Life Unlimited Smith & Nephew exists to restore HIGHLIGHTS
More informationPreliminary Results January September 2014
Creating the Leading Digital Telco Preliminary Results January September 2014 November 10, 2014 Disclaimer This document contains statements that constitute forward-looking statements and expectations
More informationA Leading Global Health Care Group
A Leading Global Health Care Group Roadshow Copenhagen October 6, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.
More informationHill-Rom: Acquiring Mortara Instrument Complementary Combination Strengthens Clinical Focus on Diagnostic Cardiology and Patient Monitoring
Hill-Rom: Acquiring Mortara Instrument Complementary Combination Strengthens Clinical Focus on Diagnostic Cardiology and Patient Monitoring January 10, 2017 Forward Looking Statements This presentation
More informationResMed to Acquire Brightree for $800 Million
ResMed Contacts: For News Media For Investors Alison Graves Agnes Lee Global Corporate Communications Senior Director, Investor Relations O: +1.858.836.6731 O: +1.858.836.5971 news@resmed.com investorrelations@resmed.com
More informationFor personal use only
ResMed Contacts: For News Media For Investors Alison Graves Agnes Lee Global Corporate Communications Senior Director, Investor Relations O: +1.858.836.6731 O: +1.858.836.5971 news@resmed.com investorrelations@resmed.com
More informationPfizer To Acquire Hospira
For immediate release: February 5, 2015 Media Contact: Joan Campion (212) 733-2798 Investor Contact: Ryan Crowe (212) 733-8160 Pfizer To Acquire Hospira - Transaction will significantly enhance Pfizer
More informationYOUR GOODS. OUR BEST. YOUR GOODS. OUR BEST.
ROADRUNNER TRANSPORTATION SYSTEMS Full Year 2017 & First Quarter 2018 Management Call YOUR GOODS. OUR BEST. YOUR GOODS. OUR BEST. SAFE HARBOR STATEMENT This presentation contains forward-looking statements
More informationPlumbing Products. Richard O Reagan / Group President, Global Plumbing
Plumbing Products Richard O Reagan / Group President, Global Plumbing Safe Harbor Statement This presentation contains statements that reflect our views about our future performance and constitute forward-looking
More informationCredit Suisse 5 th Annual Industrials Conference. Jim Lico President & CEO
Credit Suisse 5 th Annual Industrials Conference Jim Lico President & CEO FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Statements in this presentation that are not strictly historical, statements
More information